Table 2.
General features of the studies included
| Features | No of DM patients in the short term group (n) | No of DM patients in the long term group (n) | Type of study | Enrollment period | Duration of DAPT use (months) |
|---|---|---|---|---|---|
| Brar2008 | 378 | 371 | OB | 2002–2004 | <9 vs > 9 |
| I-LOVE IT 2 | 211 | 203 | RCT | 2012–2015 | 6 vs 12 |
| ISAR-SAFE | 495 | 484 | RCT | 2008–2014 | 6 vs 12 |
| Tarantini2016 | 206 | 223 | RCT | 2009–2014 | 6 vs > 12 |
| ARCTIC | 222 | 198 | RCT | 2009–2011 | <12 vs >12 |
| OPTIMIZE | 554 | 549 | RCT | 2010–2015 | 3 vs 12 |
| RESET | 316 | 305 | RCT | 2009–2010 | 3 vs 12 |
| EXCELLENT | 272 | 278 | RCT | 2008–2009 | 6 vs 12 |
| PEGASUS | 1950 | 1574 | RCT | 2010–2013 | <12 vs > 12 |
| DAPT | 1481 | 1556 | RCT | 2009–2011 | 12 vs 30 |
| Sardella2011 | 133 | 139 | OB | 2005–2006 | 12 vs > 12 |
| PRODIGY | 35 | 36 | RCT | 2006–2012 | 6 vs 24 |
| Thukkani2015 | 6568 | 5949 | OB | 2002–2006 | 12 vs > 12 |
| ENDEAVOR | 198 | 183 | RCT | 2005–2011 | 12 vs > 24 |
| ITALIC | 331 | 344 | RCT | 2011–2015 | 6 vs 24 |
| Total no of patients (n) | 13,350 | 12,392 |
Abbreviations: DM diabetes mellitus, DAPT dual antiplatelet therapy, RCT randomized controlled trials, OS observational studies